Exact Mass: 412.2362

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Trandolapril-d5 Diketopiperazine

ethyl (2R)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxo-octahydro-3H-piperazino[1,2-a]indol-2-yl]-4-phenylbutanoate

Trandolapril-d5 Diketopiperazine is a metabolite of trandolapril. Trandolapril is an ACE inhibitor used to treat high blood pressure, it may also be used to treat other conditions. It is marketed by Abbott Laboratories with the brand name Mavik. (Wikipedia)

Asebotoxin

3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Lanabecestat

4-methoxy-5-methyl-6-[5-(prop-1-yn-1-yl)pyridin-3-yl]-3H-dispiro[cyclohexane-1,2-indene-1,2-imidazole]-4-amine

3alpha-hydroxy-beta-eudesmol-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-beta-eudesmol-

Grayanotoxin-I

C22H36O7

secoscabronine M

Penicolinate A

5,6-dehydro-alpha-eudesmol-(alpha-xylopyranoside-2-O-acetate)|5,6-dehydro-alpha-eudesmol-

9-hydroxy-3-O-(2-O-acetyl-beta-D-xylopyranosyl)-nerolidol

12,13-dimethoxy-20-methyl-ibogamine-18-carboxylic acid methyl ester|12,13-Dimethoxycoronaridin

15-hydroxy-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|15-hydroxy-gamma-eudesmol-

C22H36O7_Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate, (3beta,6beta,14R,16alpha)

NCGC00168796-02_C22H36O7_Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate, (3beta,6beta,14R,16alpha)-

grayanotoxin I

A tetracyclic diterpenoid that is grayanotoxane in which the pro-R hydrogen at position 14 is substituted by an acetoxy group and in which the 3beta-, 5-, 6beta-, 10-, and 16- positions are substituted by hydroxy groups. D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Grayanotoxin I_major

Grayanotoxin I_38.4\\%

Ile Pro Pro Ser

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

Ile Pro Ser Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

Ile Ser Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

Leu Pro Pro Ser

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

Leu Pro Ser Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

Leu Ser Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

Pro Ile Pro Ser

(2S)-3-hydroxy-2-{[(2S)-1-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

Pro Ile Ser Pro

(2S)-1-[(2S)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanoyl]pyrrolidine-2-carboxylic acid

Pro Leu Pro Ser

(2S)-3-hydroxy-2-{[(2S)-1-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

Pro Leu Ser Pro

(2S)-1-[(2S)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanoyl]pyrrolidine-2-carboxylic acid

Pro Pro Ile Ser

(2S)-3-hydroxy-2-[(2S,3S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]propanoic acid

Pro Pro Leu Ser

(2S)-3-hydroxy-2-[(2S)-4-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]propanoic acid

Pro Pro Ser Ile

(2S,3S)-2-[(2S)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

Pro Pro Ser Leu

(2S)-2-[(2S)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

Pro Pro Thr Val

(2S)-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]-3-methylbutanoic acid

Pro Pro Val Thr

(2S,3R)-3-hydroxy-2-[(2S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]butanoic acid

Pro Ser Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

Pro Ser Leu Pro

(2S)-1-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

Pro Ser Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

Pro Ser Pro Leu

(2S)-2-{[(2S)-1-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

Pro Thr Pro Val

(2S)-2-{[(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

Pro Thr Val Pro

(2S)-1-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

Pro Val Pro Thr

(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}butanoic acid

Pro Val Thr Pro

(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoyl]pyrrolidine-2-carboxylic acid

Ser Ile Pro Pro

(2S)-1-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

Ser Leu Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

Ser Pro Ile Pro

(2S)-1-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

Ser Pro Leu Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

Ser Pro Pro Ile

(2S,3S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

Ser Pro Pro Leu

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

Thr Pro Pro Val

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

Thr Pro Val Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

Thr Val Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

Val Pro Pro Thr

(2S,3R)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

Val Pro Thr Pro

(2S)-1-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

Val Thr Pro Pro

(2S)-1-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

Trandolapril lactam (RU 46178)

(BENZO[3,4-D]1,3-DIOXOLAN-5-YLMETHYLENE)METHANE-1,1-DICARBONITRILE

2-DEOXY-ALPHA-D-RIBOSE 1-PHOSPHATE BIS(CYCLOHEXYLAMINE) SALT

C17H37N2O7P (412.2338)

Lanabecestat

C78272 - Agent Affecting Nervous System

2-Methyl-3-phenyl-5-propyl-7-[4-(2-pyridinyl)-1-piperazinyl]pyrazolo[1,5-a]pyrimidine

C25H28N6 (412.2375)

N-(phenylmethyl)-3-[3,4,6-trimethyl-1-(4-methylphenyl)-5-pyrazolo[3,4-b]pyridinyl]propanamide

N,N-dimethyl-3-[4-[(1R,5S)-6-(3-pyridinylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide

N,N-dimethyl-4-[4-[(1R,5S)-6-(2-pyridinylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide

[(1S,3R,4R,6S,8S,9R,10R,13R,14R,16S)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyl-16-tetracyclo[11.2.1.01,10.04,8]hexadecanyl] acetate

(1s,4ar,5r,8ar)-5-{2-[(2r,3r,4s,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1s,4as,5r,8as)-5-{2-[(2r,3s,4r,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1s,2r,4as,8s,8ar)-5-(3,5-dihydroxy-3-methylpentyl)-8-hydroxy-1-(hydroxymethyl)-1,4a,6-trimethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-2-yl acetate

(1s,4as,5r,8as)-5-{2-[(2s,3r,4s,5s)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

4,5-dihydroxy-2-({2-[8-(hydroxymethyl)-4a-methyl-3,4,5,6,7,8-hexahydro-2h-naphthalen-2-yl]propan-2-yl}oxy)oxan-3-yl acetate

(1s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-4,6,9,14,16-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(2s,3r,4s,5r)-2-({2-[(2r,4as,7r,8ar)-7-hydroxy-4a-methyl-8-methylidene-octahydronaphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

methyl 2-[(1s,9s,12s,19s)-6-methoxy-8-propanoyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-12-yl]acetate

(5e)-4,7,8-trihydroxy-10-oxo-2-pentyl-2,3,4,7,8,9-hexahydrooxecin-3-yl (2e)-2,4-dimethylhex-2-enoate

(1s,3r,4r,6s,8r,9r,10r,13r,14r,16s)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

5-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

methyl 2-[(1r,9r,12s,19r)-6-methoxy-8-propanoyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-12-yl]acetate

(1r,3s,4s,6r,8s,9r,10s,13s,14s,16r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

[(1s,2r,4as,8s,8ar)-5-(3,5-dihydroxy-3-methylpentyl)-2,8-dihydroxy-1,4a,6-trimethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]methyl acetate

(1s,3r,4r,6s,8s,9r,10r,13r,14r,16s)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

3a,11a-dihydroxy-1,3-dimethoxy-3b,6,9a-trimethyl-decahydro-1h-phenanthro[1,2-c]furan-6-carboxylic acid

(4r,5r,6s,8r,9s)-9-(acetyloxy)-4,6,8-trimethyl-3,7-dioxoundecan-5-yl (2r)-2-methyl-3-oxopentanoate

(1r,3r,4r,6s,8r,9s,10r,13s,14r,16r)-4,6,9,14,16-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(2s,3r,4s,5r)-2-({2-[(2r,4ar,8s)-8-(hydroxymethyl)-4a-methyl-3,4,5,6,7,8-hexahydro-2h-naphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

4,5-dihydroxy-2-[(9-hydroxy-3,7,11-trimethyldodeca-1,6,10-trien-3-yl)oxy]oxan-3-yl acetate

(2r,3r,4s,5r)-4-(acetyloxy)-2-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-5-hydroxyoxan-3-yl (2r)-2-methylbutanoate

(1r,3s,3ar,3br,5as,6s,9ar,9br,11ar)-3a,11a-dihydroxy-1,3-dimethoxy-3b,6,9a-trimethyl-decahydro-1h-phenanthro[1,2-c]furan-6-carboxylic acid

methyl 2-{6-methoxy-8-propanoyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-12-yl}acetate

(2s,3r,4s,5r)-2-({2-[(2r,4ar)-8-(hydroxymethyl)-4a-methyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

(1s,2r,3s,4r)-2-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-(hydroxymethyl)cyclohex-5-ene-1,2,3,4-tetrol

4,5-dihydroxy-2-({2-[8-(hydroxymethyl)-4a-methyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)oxan-3-yl acetate